Using comorbidity indexes to predict costs for head and neck cancer

Christopher S. Hollenbeak, Brendan C. Stack, Stephen M. Daley, Jay F. Piccirillo

Research output: Contribution to journalArticle

20 Scopus citations

Abstract

Objective: To determine whether the general Charlson Comorbidity Index (CCI) and the head and neck cancer-specific Washington University Head and Neck Cancer Comorbidity Index (WUHNCCI) were useful for predicting cost of treatment for elderly patients with head and neck cancer. Design: Retrospective, observational study. Patients: A total of 1780 Medicare patients with head and neck cancer, who were treated between 1984 and 1994, were analyzed using the Surveillance, Epidemiology, and End Results (SEER)-Medicare-linked database. Main Outcome Measures: Total Medicare payments were accumulated for each patient up to 1 and 5 years. Linear regression was used to estimate the impact of the comorbidity indexes on costs, controlling for demographics, site, stage, and treatment modality. Results: Neither the WUHNCCI nor the CCI was significantly associated with 1-year costs. However, the effect of the WUHNCCI on 5-year costs was statistically significant (P<.001). A 1-point increase in the WUHNCCI from 4 to 5 was associated with an increase in 5-year costs of $2105. A 1-point increase in the WUHNCCI from 9 to 10 was associated with an increase in 5-year costs of $2837. Conclusion: These results suggest that comorbidity indexes for head and neck cancer may be useful for prognostication of patient outcomes and predicting costs.

Original languageEnglish (US)
Pages (from-to)24-27
Number of pages4
JournalArchives of Otolaryngology - Head and Neck Surgery
Volume133
Issue number1
DOIs
StatePublished - Jan 25 2007

All Science Journal Classification (ASJC) codes

  • Surgery
  • Otorhinolaryngology

Fingerprint Dive into the research topics of 'Using comorbidity indexes to predict costs for head and neck cancer'. Together they form a unique fingerprint.

  • Cite this